XML 38 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTRUCTURING, INTEGRATION AND OTHER COSTS (Tables)
 9 Months Ended
Sep. 30, 2014
B&L
  
Restructuring costs  
Schedule of major components of restructuring costs incurred in connection with acquisition-related initiatives
The following table summarizes the major components of the restructuring costs incurred in connection with the B&L Acquisition since the acquisition date through September 30, 2014:
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2013
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
155.7

 
52.8

 
—

 
25.6

 
234.1

Cash payments
 
(77.8
)
 
(52.8
)
 
—

 
(7.8
)
 
(138.4
)
Non-cash adjustments
 
11.4

 
—

 
—

 
(6.8
)
 
4.6

Balance, December 31, 2013
 
89.3

 
—

 
—

 
11.0

 
100.3

Costs incurred and/or charged to expense
 
22.5

 
—

 
—

 
6.6

 
29.1

Cash payments
 
(50.9
)
 
—

 
—

 
(3.2
)
 
(54.1
)
Non-cash adjustments
 
(2.3
)
 
—

 
—

 
(3.1
)
 
(5.4
)
Balance, March 31, 2014
 
58.6

 
—

 
—

 
11.3

 
69.9

Costs incurred and charged to expense
 
12.3

 
—

 
—

 
10.1

 
22.4

Cash payments
 
(25.7
)
 
—

 
—

 
(1.8
)
 
(27.5
)
Non-cash adjustments
 
(0.5
)
 
—

 
—

 
(0.4
)
 
(0.9
)
Balance, June 30, 2014
 
44.7

 
—

 
—

 
19.2

 
63.9

Costs incurred and charged to expense
 
8.2

 
—

 
—

 
4.5

 
12.7

Cash payments
 
(22.2
)
 
—

 
—

 
(18.7
)
 
(40.9
)
Non-cash adjustments
 
(1.7
)
 
—

 
—

 
(0.2
)
 
(1.9
)
Balance, September 30, 2014
 
$
29.0

 
$
—

 
$
—

 
$
4.8

 
$
33.8

___________________________________
(1)
Relates to B&L’s previously cancelled performance-based options and the acceleration of unvested stock options for B&L employees as a result of the B&L Acquisition. These charges were reclassified to Other (income) expense to conform to the current year presentation.
Medicis
  
Restructuring costs  
Schedule of major components of restructuring costs incurred in connection with acquisition-related initiatives
The following table summarizes the major components of the $109.2 million of restructuring costs incurred in connection with the Medicis acquisition since the acquisition date through September 30, 2014:
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2012
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
85.3

 
77.3

 
—

 
0.4

 
163.0

Cash payments
 
(78.0
)
 
(77.3
)
 
—

 
—

 
(155.3
)
Non-cash adjustments
 
4.1

 
—

 
—

 
(0.2
)
 
3.9

Balance, December 31, 2012
 
11.4

 
—

 
—

 
0.2

 
11.6

Costs incurred and/or charged to expense
 
20.0

 
—

 
—

 
3.5

 
23.5

Cash payments
 
(31.4
)
 
—

 
—

 
(3.6
)
 
(35.0
)
Non-cash adjustments
 
0.3

 
—

 
—

 
(0.1
)
 
0.2

Balance, December 31, 2013(2)
 
$
0.3

 
$
—

 
$
—

 
$
—

 
$
0.3

____________________________________
(1)
Relates to the acceleration of unvested stock options, restricted stock awards, and share appreciation rights for Medicis employees that was triggered by the change in control. These charges were reclassified to Other (income) expense to conform to the current year presentation.

(2)
The Company has not recognized any restructuring charges, and made a payment of $0.1 million, in the nine-month period ended September 30, 2014 with respect to the Medicis acquisition-related initiatives. In the nine-month period ended September 30, 2013, the Company recognized $23.1 million of restructuring charges and made payments of $34.4 million.